Galamiton, Aisheya T.
HRN: 25-74-74 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/24/2025
CEFTRIAXONE 1G (VIAL)
01/24/2025
01/24/2025
IV
2g
Single Dose
Cholecystitis
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes